Sugi Predict

Sugi Predict / Compounds / SCHEMBL340819

SCHEMBL340819

SCHEMBL340819

CCC(=O)Nc1c(-c2ccccc2)cccc1C(C)C(=O)O.CN(C)C(=O)[C@H](N)c1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 5/20 0.39
▸ KCNQ2 O43526 1/20 0.35
▸ LMNA P02545 3/20 0.34
▸ ALDH1A1 P00352 3/20 0.34
▸ GAA P10253 2/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ SOAT2 O75908 1/20 0.34
▸ SOAT1 P35610 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ HTT P42858 2/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ RORC P51449 1/20 0.34
▸ CXCL8 P10145 1/20 0.34
▸ USP2 O75604 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ IKBKB O14920 1/20 0.34
▸ SLC1A3 P43003 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL338541 0.86 MAPT (0.43) MAPTALDH1A1GAARAB9ASOAT2
SCHEMBL341491 0.77 SOAT1 (0.46) MAPTLMNAALDH1A1RAB9ASOAT2
SCHEMBL339362 0.73 CXCL8 (0.46) MAPTLMNAALDH1A1RAB9AHPGD
SCHEMBL341017 0.72 KMT2A (0.45) MAPTLMNAALDH1A1RAB9AHPGD
Hydrochloric Acid SCHEMBL3218143 0.71 ALDH1A1 (0.44) LMNAALDH1A1GAAKDM4E
Hydrochloric Acid SCHEMBL3218133 0.71 ALDH1A1 (0.44) LMNAALDH1A1GAAKDM4E
Hydrochloric Acid SCHEMBL14152561 0.71 ALDH1A1 (0.44) LMNAALDH1A1GAAKDM4E
SCHEMBL339798 0.70 CXCL8 (0.34) MAPTKCNQ2LMNAHPGDHTT
SCHEMBL13688832 0.69 ALOX5 (0.44) LMNAALDH1A1GAAKDM4E
SCHEMBL1206430 0.69 ALOX5 (0.44) LMNAALDH1A1GAAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9181175-B2 Process for manufacture and resolution of 2-acylamino-3-diphenylpropanoic acid Zhejiang Jiuzhous Pharmaceutical Co., Ltd. (CN) 2015-11-10 — — US disclosed
US-20140179947-A1 PROCESS FOR MANUFACTURE AND RESOLUTION OF 2-ACYLAMINO-3-DIPHENYLPROPANOIC ACID ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD. (CN) 2014-06-26 — — US disclosed
US-8703990-B2 Process for manufacture and resolution of 2-acylamino-3-diphenylpropanoic acid Zhejiang Jiuzhous Pharmaceutical Co., Ltd. (CN) 2014-04-22 — — US disclosed
US-20120016151-A1 PROCESS FOR MANUFACTURE AND RESOLUTION OF 2-ACYLAMINO-3-DIPHENYLPROPANOIC ACID NOVARTIS AG (CH) 2012-01-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140179947-A1 PROCESS FOR MANUFACTURE AND RESOLUTION OF 2-ACYLAMINO-3-DIPHENYLPROPANOIC ACID DNPEP, MME, DPP7 MAPT 1676/4885KCNQ2 3905/4885LMNA 1839/4885
US-20120016151-A1 PROCESS FOR MANUFACTURE AND RESOLUTION OF 2-ACYLAMINO-3-DIPHENYLPROPANOIC ACID DNPEP, MME, DPP7 MAPT 1676/4885KCNQ2 3905/4885LMNA 1839/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.